New antipsychotic drugs for the treatment of agitation and psychosis in Alzheimer’s disease: focus on brexpiprazole and pimavanserin [version 1; peer review: 2 approved]

by Filippo Caraci, Mario Santagati, Giuseppe Caruso, Dario Cannavò, Gian Marco Leggio, Salvatore Salomone, Filippo Drago
Published 2020-07-01